迷走神经的

The vagolytic effect of this medication reduces heart rate variability, thereby stabilizing the patient's cardiac condition.
这种药物的抗迷走神经效应降低了心率变异性，从而稳定了患者的心脏状况。
After administering the vagolytic agent, the patient's bronchial constriction was alleviated due to reduced parasympathetic activity.
给予抗迷走神经药剂后，由于副交感神经活动减少，患者的支气管收缩得到缓解。
Vagolytic drugs are often used during surgery to prevent bradycardia caused by overstimulation of the vagus nerve.
在手术期间常使用抗迷走神经药物以防止因迷走神经过度兴奋引起的窦性心动过缓。
In patients with chronic obstructive pulmonary disease (COPD), vagolytic therapy can improve respiratory function by reducing airway resistance.
对于慢性阻塞性肺疾病（COPD）患者，抗迷走神经疗法可以通过降低气道阻力来改善呼吸功能。
The vagolytic properties of atropine make it an effective treatment for poisonings that cause excessive stimulation of the parasympathetic nervous system.
阿托品的抗迷走神经特性使其成为治疗引起副交感神经系统过度兴奋中毒的有效手段。
By blocking the action of acetylcholine on the vagus nerve, vagolytics can increase heart rate and contractility in patients experiencing bradyarrhythmias.
通过阻断乙酰胆碱对迷走神经的作用，抗迷走神经药物可以增加心动过缓患者的心率和收缩力。
Vagolytic agents were administered prophylactically to the patient before undergoing electroconvulsive therapy to avoid adverse cardiovascular responses.
在患者接受电休克疗法之前预防性给予抗迷走神经药物，以避免出现不良心血管反应。
In contrast to vagotonic drugs, vagolytics decrease the influence of the parasympathetic nervous system on various organs and functions.
与迷走神经兴奋药相反，抗迷走神经药物可以减少副交感神经系统对各种器官和功能的影响。
During anesthesia induction, a vagolytic drug may be used to counteract the excessive bradycardia often seen when anesthetics suppress the sympathetic nervous system.
在麻醉诱导过程中，可能会使用抗迷走神经药物来对抗当麻醉药抑制交感神经系统时经常出现的过度心动过缓。
Vagal tone suppression through vagolytic agents is crucial in managing some types of supraventricular tachycardia to restore normal sinus rhythm.
通过抗迷走神经药物抑制迷走神经张力在管理某些类型的室上性心动过速恢复正常的窦性心律方面至关重要。